Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

1.

The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis.

Albertsen PC, Hanley JA, Harlan LC, Gilliland FD, Hamilton A, Liff JM, Stanford JL, Stephenson RA.

J Urol. 2000 Apr;163(4):1138-43.

PMID:
10737483
[PubMed - indexed for MEDLINE]
2.

Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer.

Huncharek M, Muscat J.

Cancer Invest. 1995;13(1):31-5.

PMID:
7530590
[PubMed - indexed for MEDLINE]
3.

Serum prostate-specific antigen as a predictor of staging abdominal/pelvic computed tomography in newly diagnosed prostate cancer.

Huncharek M, Muscat J.

Abdom Imaging. 1996 Jul-Aug;21(4):364-7.

PMID:
8661585
[PubMed - indexed for MEDLINE]
4.

Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 588 patients.

Lee N, Newhouse JH, Olsson CA, Benson MC, Petrylak DP, Schiff PB, Bagiella E, Malyszko B, Ennis RD.

Urology. 1999 Sep;54(3):490-4.

PMID:
10475360
[PubMed - indexed for MEDLINE]
5.

The utilization of Gleason grade as the primary criterion for ordering nuclear bone scan in newly diagnosed prostate cancer patients.

Ritenour CW, Abbott JT, Goodman M, Alazraki N, Marshall FF, Issa MM.

ScientificWorldJournal. 2009 Oct 2;9:1040-5. doi: 10.1100/tsw.2009.113.

PMID:
19802499
[PubMed - indexed for MEDLINE]
Free Article
6.

Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients.

Lee N, Fawaaz R, Olsson CA, Benson MC, Petrylak DP, Schiff PB, Bagiella E, Singh A, Ennis RD.

Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1443-6.

PMID:
11121646
[PubMed - indexed for MEDLINE]
7.

The value of a baseline bone scan in patients with newly diagnosed prostate cancer.

Lin K, Szabo Z, Chin BB, Civelek AC.

Clin Nucl Med. 1999 Aug;24(8):579-82.

PMID:
10439178
[PubMed - indexed for MEDLINE]
8.

The role of imaging studies and molecular markers for selecting candidates for radical prostatectomy.

Moul JW, Kane CJ, Malkowicz SB.

Urol Clin North Am. 2001 Aug;28(3):459-72. Review.

PMID:
11590806
[PubMed - indexed for MEDLINE]
9.

Predictors of metastatic disease in men with biochemical failure following radical prostatectomy.

Okotie OT, Aronson WJ, Wieder JA, Liao Y, Dorey F, DeKERNION JB, Freedland SJ.

J Urol. 2004 Jun;171(6 Pt 1):2260-4.

PMID:
15126798
[PubMed - indexed for MEDLINE]
10.

Baseline staging of newly diagnosed prostate cancer: a summary of the literature.

Abuzallouf S, Dayes I, Lukka H.

J Urol. 2004 Jun;171(6 Pt 1):2122-7. Review.

PMID:
15126770
[PubMed - indexed for MEDLINE]
11.

When is a bone scan study appropriate in asymptomatic men diagnosed with prostate cancer?

Pal RP, Thiruudaian T, Khan MA.

Asian J Androl. 2008 Nov;10(6):890-5. doi: 10.1111/j.1745-7262.2008.00427.x.

PMID:
18958353
[PubMed - indexed for MEDLINE]
Free Article
12.

Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan.

Kosuda S, Yoshimura I, Aizawa T, Koizumi K, Akakura K, Kuyama J, Ichihara K, Yonese J, Koizumi M, Nakashima J, Fujii H.

Cancer. 2002 Feb 15;94(4):964-72.

PMID:
11920464
[PubMed - indexed for MEDLINE]
Free Article
13.
14.

Value of prostate-specific antigen in the staging of Taiwanese patients with newly diagnosed prostate cancer.

Meng E, Sun GH, Wu ST, Chuang FP, Lee SS, Yu DS, Yen CY, Chen HI, Chang SY.

Arch Androl. 2003 Nov-Dec;49(6):471-4.

PMID:
14555332
[PubMed - indexed for MEDLINE]
15.

Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: the Aarau experience.

Recker F, Kwiatkowski MK, Huber A, Stamm B, Lehmann K, Tscholl R.

J Urol. 2001 Sep;166(3):851-5.

PMID:
11490232
[PubMed - indexed for MEDLINE]
16.

When is bone scintigraphy necessary in the assessment of newly diagnosed, untreated prostate cancer?

Haukaas S, Roervik J, Halvorsen OJ, Foelling M.

Br J Urol. 1997 May;79(5):770-6.

PMID:
9158517
[PubMed - indexed for MEDLINE]
17.

Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital.

O'Sullivan JM, Norman AR, Cook GJ, Fisher C, Dearnaley DP.

BJU Int. 2003 Nov;92(7):685-9.

PMID:
14616446
[PubMed - indexed for MEDLINE]
18.

Diagnosis of bone metastasis in men with prostate cancer by measurement of serum ICTP in combination with alkali phosphatase and prostate-specific antigen.

Kataoka A, Yuasa T, Kageyama S, Tsuchiya N, Habuchi T, Iwaki H, Narita M, Okada Y, Yoshiki T.

Clin Oncol (R Coll Radiol). 2006 Aug;18(6):480-4.

PMID:
16909972
[PubMed - indexed for MEDLINE]
19.

Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml?

Heinisch M, Dirisamer A, Loidl W, Stoiber F, Gruy B, Haim S, Langsteger W.

Mol Imaging Biol. 2006 Jan-Feb;8(1):43-8.

PMID:
16315004
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk